Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06724146 · ClinicalTrials.gov registry record · NA
Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance
A NA study of Skin Lax and Muscle Strength, sponsored by Sofwave Medical.
- Active
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06724146: Active NA study of Skin Lax and Muscle Strength, sponsored by Sofwave Medical.
NCT06724146 is a NA study of Skin Lax and Muscle Strength that is active but no longer recruiting, run by Sofwave Medical. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06724146, a NA study of Skin Lax and Muscle Strength, is active but no longer recruiting, sponsored by Sofwave Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Open-label, non-randomized, prospective, multi-center, self-controlled clinical study.
Primary Outcome
Rate of improvement in the appearance of lax skin and in the strength and tone muscles in the upper arms following Sofwave and Pure Impact combined treatment based on Global Aesthetic Improvement Scale, as evaluated by independent masked reviewers.
Conditions Studied
Interventions
- DEVICE Sofwave and Pure Impact
Study Locations (1)
Tennessee
- Tennessee Clinical Research Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-08-05 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
What the registry record for NCT06724146 still lists
NCT06724146 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Skin Lax and Muscle Strength appearing as the primary indexed condition, and to 1 intervention - of which Sofwave and Pure Impact is the first listed.
NCT06724146 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06724146 about?
NCT06724146 is a clinical study titled "Combined Treatment Sofwave and Pure Impact to Strength and Tone Muscles and Improve Lax Skin Appearance". Open-label, non-randomized, prospective, multi-center, self-controlled clinical study.
What is the current status of trial NCT06724146?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-08-05. Estimated completion is 2026-11-01.
What conditions does trial NCT06724146 study?
This clinical trial studies the following conditions: Skin Lax and Muscle Strength.
What interventions are being tested in trial NCT06724146?
The interventions under investigation include: Sofwave and Pure Impact (DEVICE).
Who is sponsoring clinical trial NCT06724146?
This trial is sponsored by Sofwave Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06724146 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06724146's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI